Thomas Kartika

Hematology

1665 Aurora Ct
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.

Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.

Journal: Research and practice in thrombosis and haemostasis

Published: July 30, 2025

Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction.

Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction.

Journal: Blood advances

Published: May 29, 2024

Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry.

Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry.

Journal: Journal of thrombosis and thrombolysis

Published: October 22, 2023

Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.

Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.

Journal: European journal of haematology

Published: August 15, 2023

Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patients.

Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patients.

Journal: European journal of haematology

Published: June 02, 2023

Psychological toxicity in classical hematology.

Psychological toxicity in classical hematology.

Journal: European journal of haematology

Published: May 08, 2023

Re: Hormonal therapies and venous thrombosis: The estrogen matters! Morimont et al.

Re: Hormonal therapies and venous thrombosis: The estrogen matters! Morimont et al.

Journal: Research and practice in thrombosis and haemostasis

Published: December 09, 2022

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.

Journal: European journal of haematology

Published: May 23, 2022

The diagnosis and management of suspected lymphoma in general practice.

The diagnosis and management of suspected lymphoma in general practice.

Journal: European journal of haematology

Published: May 18, 2022

Association of PD-L1 expression, tumor mutational burden and immunotherapy with venous thrombosis in patients with solid organ malignancies.

Association of PD-L1 expression, tumor mutational burden and immunotherapy with venous thrombosis in patients with solid organ malignancies.

Journal: Thrombosis research

Published: April 09, 2022

Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.

Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.

Journal: The oncologist

Published: January 26, 2022

Assessing the risk of thromboembolism in cancer patients receiving immunotherapy.

Assessing the risk of thromboembolism in cancer patients receiving immunotherapy.

Journal: European journal of haematology

Published: September 27, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026